Axogen (AXGN)

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven, and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.

Company profile

Ticker

AXGN

Exchange

NASDAQ

Website

www.axogeninc.com

CEO

Karen L. Zaderej

Incorporated

Minnesota

Location

Florida

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Electromedical & Electrotherapeutic Apparatus

Medtronic • Varian Medical Systems • Conmed • Masimo • Natus Medical • LivaNova • Outset Medical • Fonar • Cutera • Inmode ...

Former names

LECTEC CORP /MN/

SEC CIK

0000805928

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

1.Axogen Corporation • 2.Axogen Europe GmbH • 3.Axogen Processing Corporation ...

IRS number

411301878

AXGN stock data

1M 1Y 5Y

News

From Benzinga Pro

Axogen: Q2 Earnings Insights

3 Aug 22

Axogen (NASDAQ:AXGN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Axogen beat estimated earnings by 60.0%, reporting an EPS of $-0.06 versus an estimate of $-0.15.

Axogen Q2 EPS $(0.06) Beats $(0.15) Estimate, Sales $34.50M Beat $33.85M Estimate

3 Aug 22

Axogen (NASDAQ:AXGN) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.15) by 60 percent. This is a 33.33 percent increase over losses of $(0.09) per share from the same

Earnings Scheduled For August 3, 2022

3 Aug 22

Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report quarterly earnings at $0.79 per share on revenue of $1.15 billion.

Read JMP Securities' Take On Axogen's Interim Update

20 Jul 22

Press releases

From Benzinga Pro

Axogen, Inc Reports 2022 Second Quarter Financial Results

3 Aug 22

ALACHUA, Fla. and TAMPA, Fla., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported

Axogen, Inc. to present at Canaccord Genuity's 42nd Annual Growth Conference

29 Jul 22

ALACHUA. Fla. and TAMPA, Fla, July 29, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that

Axogen, Inc. Announces Organizational Updates, Preliminary Second Quarter Revenue and Reaffirms Full-Year 2022 Financial Guidance

18 Jul 22

Organizational updates are part of plan to bring additional focus on leveraging clinical data to accelerate market development and the pace of innovation Preliminary unaudited second quarter revenue of approximately

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

26 Jul 22

12 Aug 22

31 Dec 22

Financial summary

Financial statements Chart AXGN financial data

Quarter (USD)	Jun 22	Mar 22	Dec 21	Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	18.07M	18.07M	18.07M	18.07M	18.07M	18.07M
Cash burn (monthly)	912.33K	3.44M	2.64M	2.61M	1.9M	1.55M
Cash used (since last report)	1.31M	4.93M	3.78M	3.73M	2.71M	2.22M
Cash remaining	16.77M	13.14M	14.29M	14.34M	15.36M	15.85M
Runway (months of cash)	18.4	3.8	5.4	5.5	8.1	10.2

Beta Read what these cash burn values mean

Financial data from Axogen earnings reports.

Recent insider trades

AXGN insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
10 Aug 22	Freitag Gregory Gene	Common Stock	Sell	Dispose S	No	Yes	9.696	8,886	86.16K	365,583
8 Aug 22	Freitag Gregory Gene	Common Stock	Sell	Dispose S	No	Yes	10.37	13,046	135.29K	374,469
4 Aug 22	Freitag Gregory Gene	Common Stock	Sell	Dispose S	No	Yes	10.64	24,000	255.36K	387,515
25 Jul 22	Freitag Gregory Gene	Common Stock	Payment of exercise	Dispose F	No	No	9.26	30,296	280.54K	411,515
25 Jul 22	Freitag Gregory Gene	Common Stock	Option exercise	Acquire M	No	No	3.38	83,000	280.54K	441,811
25 Jul 22	Freitag Gregory Gene	Employee Stock Option (right to purchase) Common Stock	Option exercise	Dispose M	No	No	3.38	83,000	280.54K	0
19 Jul 22	Burke William P. Mr.	Stock Option (right to purchase) Stock Option (right to purchase)	Grant	Acquire A	No	No	8.14	59,395	483.48K	0
19 Jul 22	Martinez Maria D.	Common Stock	Sale back to company	Dispose D	No	No	8.4	657	5.52K	18,197
18 Jul 22	Martinez Maria D.	Common Stock	Grant	Acquire A	No	No	0	2,571	0	18,854

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

AXGN institutional ownership history Ownership history

80.1% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	134	136	-1.5%
Opened positions	22	29	-24.1%
Closed positions	24	16	+50.0%
Increased positions	55	50	+10.0%
Reduced positions	37	35	+5.7%

13F shares	Current	Prev Q	Change
Total value	286.65M	458.96M	-37.5%
Total shares	33.61M	33.07M	+1.6%
Total puts	17K	14.9K	+14.1%
Total calls	201.7K	172.3K	+17.1%
Total put/call ratio	0.1	0.1	-2.5%

Largest owners	Shares	Value	Change
ArrowMark Colorado	5.77M	$45.79M	+1.9%
BLK Blackrock	3.02M	$23.95M	+0.2%
First Light Asset Management	2.42M	$19.24M	+6.0%
EW Healthcare Partners	1.98M	$35.48M	0.0%
Vanguard	1.92M	$15.27M	+2.1%
BAC Bank Of America	1.73M	$13.74M	+12.1%
JHG Janus Henderson	1.68M	$13.32M	-0.5%
William Blair Investment Management	1.63M	$12.93M	+2.2%
STT State Street	1.08M	$8.57M	+3.0%
D. E. Shaw & Co.	808.39K	$6.42M	+2.3%

Largest transactions	Shares	Bought/sold	Change
Bamco	0	-435.53K	EXIT
Essex Woodlands Management	0	-296.42K	EXIT
SCW Capital Management	273.25K	+273.25K	NEW
Baillie Gifford & Co	444	-250.99K	-99.8%
Jacobs Levy Equity Management	457.71K	+248.79K	+119.1%
BAC Bank Of America	1.73M	+187.21K	+12.1%
SAMG Silvercrest Asset Management	741.64K	+183.58K	+32.9%
Altrinsic Global Advisors	0	-180K	EXIT
Assenagon Asset Management	686.5K	+174.77K	+34.2%
Balyasny Asset Management	139.85K	-169.38K	-54.8%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Baxter International • Stryker • Integra Lifesciences • Predictive Technology

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abide, abundant, adamant, aforementioned, aid, appliance, architecture, ARPU, artistic, beneath, biodiversity, boldly, border, bottom, bridge, bulky, bullying, camera, century, Changjin, chronic, circumstance, civic, climate, color, Communist, condensed, contamination, Cook, cope, COVID, creditor, debtor, deeply, denouncement, density, dignified, divulged, doorstep, download, downstream, drought, Economist, emission, emphasize, empty, entice, ESG, eternal, exact, exemplified, fabricate, facsimile, fake, fandom, figure, flat, flood, foreclosure, frame, Francisco, frontier, fusion, gap, Gate, gated, GHG, globe, Gobi, greenhouse, grid, habit, habitat, harassment, hard, heartfelt, Henan, Henry, hijacking, holistic, honed, huge, Iconic, inadvertently, incredibly, induce, inequality, inflationary, innately, inseparable, intercity, intercompany, intermediate, interoperability, intervene, intracity, invalid, JP, judgement, Koala, lay, left, Lindorm, lira, livelihood, log, lot, maliciously, marker, merged, methodology, metropolitan, misuse, moderated, modular, multimedia, necessity, Neha, neutrality, Newbridge, newsfeed, null, nurturing, obligor, obsession, openly, outset, overestimate, PAG, Pangu, Panjiu, patient, Pennsylvania, pre, predicated, professor, profoundly, propelled, protocol, prove, Quark, recast, refrain, remeasured, reorganization, rescinded, reshaping, retreating, routine, sailing, SBTi, scarcity, score, Scorecard, secrecy, Sethi, ShenlongCompute, skincare, socioeconomic, SOFR, sooner, SSC, steering, stolen, storm, Stratim, subtle, summation, sunrise, super, tackle, Taocaicai, teenager, temperature, tipping, Toby, touchstone, TPG, Trustworthy, Turkish, UFLP, underestimate, undergone, unlisted, unmanned, unsuitable, uptake, veto, vetting, VK, void, volunteer, vulnerability, vulnerable, Wall, weakening, Weijian, Wharton, wildlife, Wiley, Wilmar, Wuzhen, Xiaomanlv, XU, Zeming

Removed: accessible, alternate, Amazon, Ann, applicant, Arbor, arrive, attracting, AutoNavi, avert, barring, Beverage, Blackmore, bottling, break, broaden, Carlson, Castle, cater, centralized, Chamber, charity, Cheung, Chongqing, Cola, conservation, consumed, continuation, counter, credited, Custody, Dean, depersonalized, Didi, differentiate, digitalizing, digitized, Donald, drinking, driver, DSM, Easyhome, ekholm, eleven, embrace, empowerment, enabler, enact, Eric, Ericsson, examined, exceptionally, extending, factor, fan, fast, flag, footprint, Fortune, generation, Gigamedia, Google, Grup, guaranteed, Hema, Holdco, Huawei, Huitongda, Hundsun, hungry, impoverished, incubate, incubation, ineffective, injection, innovator, INSEAD, intergenerational, KTH, leveled, leveraged, levying, LLC, Luyuan, MBA, McKinsey, Michigan, missing, mutually, Nation, native, noncontrolled, Nonemployee, opened, outsource, outsourcing, Patricia, Pepsi, PepsiCo, persuading, precautionary, predominantly, preference, preservation, Proctor, prosper, protected, Raptor, reclassification, recover, remediation, Renmin, repackaging, replicable, reproduce, researching, retaining, Reunion, reusable, Roundtrip, Royal, RSU, Ruhnn, Sat, scanning, speedy, stability, stayed, studied, supervisory, Swedish, Taiwan, Tencent, Ticaret, tightened, transforming, TransInfo, Turkey, Umeng, unconsolidated, underscored, uploading, ve, visit, VML, warehousing, Weibo, Wilmington, Xiandong, ZTE, ZTO

From filing 20-F 2022 FY

Financial reports

20-F

2022 FY

Annual report (foreign)

26 Jul 22

20-F

2021 FY

Annual report (foreign)

27 Jul 21

20-F

2020 FY